{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06299748",
            "orgStudyIdInfo": {
                "id": "ARGX-113-PAC-2206"
            },
            "organization": {
                "fullName": "argenx",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.",
            "officialTitle": "A Worldwide Pregnancy Safety Study To Assess Maternal, Fetal, And Infant Outcomes Following Exposure To Efgartigimod During Pregnancy And/Or Breastfeeding",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-worldwide-pregnancy-safety-study-to-assess-maternal-fetal-and-infant-outcomes-following-exposure-to-efgartigimod-during-pregnancy-and-or-breastfeeding"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-05-02",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2033-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2033-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-02-22",
            "studyFirstSubmitQcDate": "2024-03-01",
            "studyFirstPostDateStruct": {
                "date": "2024-03-08",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-29",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-30",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "argenx",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a multi-country, prospective safety study of pregnant women exposed to efgartigimod any time within 25 days prior to conception or any time during pregnancy. Women exposed to efgartigimod only during breastfeeding will also be eligible to enroll. Background rates of major congenital malformations (MCMs) will be obtained from populations within the same countries/regions as the countries/regions in which the VYVGART IV or SC-exposed pregnancies were reported."
        },
        "conditionsModule": {
            "conditions": [
                "Myasthenia Gravis"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": true,
            "targetDuration": "1 Year",
            "designInfo": {
                "observationalModel": "OTHER",
                "timePerspective": "OTHER"
            },
            "enrollmentInfo": {
                "count": 279,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Retrospective Pregnancy",
                    "description": "woman is no longer pregnant at time of study enrollment but was exposed to efgartigimod any time within 25 days prior to conception or any time during pregnancy",
                    "interventionNames": [
                        "Biological: Efgartigimod"
                    ]
                },
                {
                    "label": "Prospective Pregnancy",
                    "description": "woman is pregnant or breastfeeding at time of study enrollment.",
                    "interventionNames": [
                        "Biological: Efgartigimod"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "Efgartigimod",
                    "description": "Efgartigimod IV or SC",
                    "armGroupLabels": [
                        "Prospective Pregnancy",
                        "Retrospective Pregnancy"
                    ],
                    "otherNames": [
                        "Vyvgart"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Pregnancy outcomes",
                    "description": "Pregnancy outcomes: Spontaneous abortion; Elective or therapeutic abortion; Fetal death/stillbirth ; Molar or ectopic pregnancy; Live birth (Preterm delivery; Fullterm delivery)",
                    "timeFrame": "up to 10 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Congenital malformations",
                    "description": "Congenital malformations (CDC 2020b) identified in the developing fetus, neonate, or infant: Major congenital malformations (MCMs); Minor congenital malformations",
                    "timeFrame": "up to 10 years"
                },
                {
                    "measure": "The number of observed other events of interest in the developing neonate and infant (such as hospitalizations for serious illness)",
                    "description": "Other events of interest identified in the developing neonate and infant (Hospitalizations for serious illness; Potential adverse reactions to medications; Growth and development milestones as described by the Centers for Disease Control and Prevention or other accepted standard assessments; Infant developmental deficiency; Postnatal growth deficiency or failure to thrive (FTT); Neonatal and infant mortality; Infections; Transient neonatal myasthenia; Vaccination and vaccine reactions",
                    "timeFrame": "up to 10 years"
                },
                {
                    "measure": "Maternal complications of pregnancy",
                    "description": "Maternal complications of pregnancy, including but not limited to: Premature rupture of membranes (PROM); Preterm PROM (PPROM); Pre-eclampsia; Gestational hypertension; Eclampsia; Proteinuria; Gestational diabetes; Intrauterine growth restriction (IUGR); Polyhdramnios",
                    "timeFrame": "up to 10 years"
                },
                {
                    "measure": "Maternal infections",
                    "timeFrame": "up to 10 years"
                },
                {
                    "measure": "The number of observed fetal growth deficiency",
                    "timeFrame": "up to 10 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Women with exposure to efgartigimod any time within 25 days prior to conception or any time during pregnancy, or women with exposure to efgartigimod during breastfeeding. The timeframe of 25 days prior to conception is calculated based on five times the efgartigimod half-life, which is 3 to 5 days.\n* Written informed consent or eConsent (depending on country regulations) (for adolescents under the age of majority, written informed assent or eConsent by the pregnant minor (where applicable) and written informed consent or eConsent by the parent/legal guardian).\n\nExclusion Criteria:\n\n* None",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Pregnant women or women no longer pregnant at the time of study enrollment but exposed to efgartigimod any time within 25 days prior to conception or any time during the pregnancy.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Sabine Coppieters, MD",
                    "role": "CONTACT",
                    "phone": "857-350-4834",
                    "email": "Clinicaltrials@argenx.com"
                }
            ],
            "locations": [
                {
                    "facility": "United BioSource LLC",
                    "status": "RECRUITING",
                    "city": "Morgantown",
                    "state": "West Virginia",
                    "zip": "26508",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sabine Coppieters, MD",
                            "role": "CONTACT",
                            "phone": "857-350-4834",
                            "email": "clinicaltrials@argenx.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.62953,
                        "lon": -79.9559
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "UNDECIDED"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009157",
                    "term": "Myasthenia Gravis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020361",
                    "term": "Paraneoplastic Syndromes, Nervous System"
                },
                {
                    "id": "D000009423",
                    "term": "Nervous System Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000010257",
                    "term": "Paraneoplastic Syndromes"
                },
                {
                    "id": "D000020274",
                    "term": "Autoimmune Diseases of the Nervous System"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000019636",
                    "term": "Neurodegenerative Diseases"
                },
                {
                    "id": "D000020511",
                    "term": "Neuromuscular Junction Diseases"
                },
                {
                    "id": "D000009468",
                    "term": "Neuromuscular Diseases"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12112",
                    "name": "Myasthenia Gravis",
                    "asFound": "Myasthenia Gravis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M13170",
                    "name": "Paraneoplastic Syndromes",
                    "relevance": "LOW"
                },
                {
                    "id": "M22160",
                    "name": "Paraneoplastic Syndromes, Nervous System",
                    "relevance": "LOW"
                },
                {
                    "id": "M12367",
                    "name": "Nervous System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22094",
                    "name": "Autoimmune Diseases of the Nervous System",
                    "relevance": "LOW"
                },
                {
                    "id": "M21558",
                    "name": "Neurodegenerative Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22297",
                    "name": "Neuromuscular Junction Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12411",
                    "name": "Neuromuscular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T3973",
                    "name": "Myasthenia Gravis",
                    "asFound": "Myasthenia Gravis",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}